Skip to main content
. Author manuscript; available in PMC: 2019 Jul 2.
Published in final edited form as: Mol Pharm. 2018 May 30;15(7):2606–2613. doi: 10.1021/acs.molpharmaceut.8b00133

Figure 4.

Figure 4

Immunofluorescent and H&E staining of tumor tissues. Colocalization of CD31 and CD105, indicated by yellow arrows, shows angiogenic vessels. H&E staining visualized notable damage to 90Y-treated tumors, with red arrows pointing out representative damaged areas, and blue arrows indicating hemorrhaging.